CIK 0001835579 · <br>Emerging growth company
ImageneBio, Inc.
Sign in to watch- Ticker
- IMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811697316
- Phone
- 857-343-8292
- Business address
- 12526 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Former names
- Ikena Oncology, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-21 | Stampacchia Otello Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 | ||
| 2021-12-21 | FORMELA JEAN FRANCOIS Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 | ||
| 2021-12-21 | Dukes Iain D. Director | Grant or award · Stock Option (Right to Buy) | +23,419 | 23,419 | ||
| 2021-12-21 | Renaud Ronald C JR Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 | ||
| 2021-12-21 | Bonita David P Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 | ||
| 2021-12-14 | FORMELA JEAN FRANCOIS Director | Sale | −5,959 | $14.00 | $83K | 1,241,935 |
| 2021-12-14 | Atlas Venture Fund XI, L.P. 10% owner | Sale | −5,959 | $14.00 | $83K | 1,241,935 |
| 2021-12-13 | FORMELA JEAN FRANCOIS Director | Sale | −8,330 | $14.64 | $122K | 1,247,894 |
| 2021-12-13 | Atlas Venture Fund XI, L.P. 10% owner | Sale | −8,330 | $14.64 | $122K | 1,247,894 |
| 2021-12-10 | FORMELA JEAN FRANCOIS Director | Sale | −11,989 | $15.03 | $180K | 1,256,224 |
| 2021-12-10 | Atlas Venture Fund XI, L.P. 10% owner | Sale | −11,989 | $15.03 | $180K | 1,256,224 |
| 2021-12-10 | Zhang Xiaoyan Michelle Chief Scientific Officer | Option exercise | +1,000 | $2.15 | $2K | 45,475 |
| 2021-12-10 | Zhang Xiaoyan Michelle Chief Scientific Officer | Sale | −1,000 | $14.76 | $15K | 44,475 |
| 2021-12-10 | Zhang Xiaoyan Michelle Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −1,000 | 25,473 | ||
| 2021-11-22 | Zhang Xiaoyan Michelle Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +176,699 | 176,699 | ||
| 2021-04-15 | Koehler Maria Director | Grant or award · Stock Option (Right to Buy) | +26,838 | 26,838 | ||
| 2021-04-15 | Koehler Maria Director | Grant or award · Stock Option (Right to Buy) | +26,838 | 26,838 | ||
| 2021-03-30 | FORMELA JEAN FRANCOIS Director | Purchase | +125,000 | $16.00 | $2.0M | 874,634 |
| 2021-03-30 | Atlas Venture Fund XI, L.P. 10% owner | Purchase | +125,000 | $16.00 | $2.0M | 874,634 |
| 2021-03-30 | Bonita David P Director | Conversion | +1,470,872 | 1,470,872 |
Page 7 of 12 · 222 trades